SCHEMBL20125882

SCHEMBL20125882

C=CC(=O)N(CCC)CCCCOC(C)=O

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
ZDHHC20 Q5W0Z9 2/20 0.47
ZDHHC2 Q9UIJ5 1/20 0.47
TSHR P16473 6/20 0.42
HPGD P15428 1/20 0.42
CYP3A4 P08684 1/20 0.38
MAPK1 P28482 1/20 0.33
ATM Q13315 1/20 0.33
HCAR2 Q8TDS4 2/20 0.33
NAAA Q02083 1/20 0.33
APP P05067 2/20 0.32
LMNA P02545 2/20 0.32
APOBEC3A P31941 1/20 0.32
APOBEC3G Q9HC16 1/20 0.32
CA12 O43570 1/20 0.32
CA2 P00918 1/20 0.32
CA9 Q16790 1/20 0.32
HSD17B10 Q99714 1/20 0.31
EPHX1 P07099 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20125875 0.95 ALDH1A1 (0.48) ALDH1A1ZDHHC20ZDHHC2TSHRHPGD
SCHEMBL20125926 0.94 ALDH1A1 (0.52) ALDH1A1ZDHHC20ZDHHC2TSHRHPGD
SCHEMBL16285074 0.94 ZDHHC20 (0.44) ALDH1A1ZDHHC20ZDHHC2TSHRHPGD
SCHEMBL20125894 0.89 ALDH1A1 (0.53) ALDH1A1ZDHHC20ZDHHC2TSHRHPGD
SCHEMBL20126050 0.89 ZDHHC20 (0.44) ALDH1A1ZDHHC20ZDHHC2TSHRHPGD
SCHEMBL20125828 0.89 ZDHHC20 (0.43) ALDH1A1ZDHHC20ZDHHC2TSHRHPGD
SCHEMBL16285095 0.89 ALDH1A1 (0.45) ALDH1A1ZDHHC20ZDHHC2TSHRHPGD
SCHEMBL20126053 0.86 NAAA (0.50) ALDH1A1ZDHHC20ZDHHC2TSHRHPGD
SCHEMBL20125829 0.86 ALDH1A1 (0.48) ALDH1A1ZDHHC20ZDHHC2TSHRHPGD
SCHEMBL20125912 0.85 ZDHHC20 (0.48) ALDH1A1ZDHHC20ZDHHC2TSHRHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11529302-B2 Composition, artificial nail composition, nail decoration material, artificial nail, stored container, image forming apparatus, and image forming method RICOH COMPANY, LTD. (JP) 2022-12-20 US disclosed
US-20210155814-A1 ACTIVE-ENERGY-RAY-CURABLE AQUEOUS COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE AQUEOUS INK, STORED CONTAINER, IMAGE FORMING APPARATUS, IMAGE FORMING METHOD, CURED PRODUCT, AND DECORATED PRODUCT RICOH COMPANY, LTD. (JP) 2021-05-27 US disclosed
US-20210061929-A1 ACTIVE-ENERGY-RAY-CURABLE COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE INK, COMPOSITION STORED CONTAINER, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING METHOD AND APPARATUS, CURED PRODUCT, AND DECORATED PRODUCT RICOH COMPANY, LTD. (JP) 2021-03-04 US disclosed
US-20200299425-A1 ACTIVE ENERGY RAY CURABLE COMPOSITION, ACTIVE ENERGY RAY CURABLE INK, COMPOSITION ACCOMMODATING CONTAINER, TWO OR THREE DIMENSIONAL IMAGE FORMING APPARATUS, TWO OR THREE DIMENSIONAL IMAGE FORMING METHOD, CURED MATTER, DECORATIVE MATTER, ARTIFICIAL NAIL COMPOSITION, NAIL DECORATIVE MATERIAL, AND ARTIFICIAL NAIL RICOH COMPANY, LTD. (JP) 2020-09-24 US disclosed
US-10781325-B2 Curable composition, curable ink, accommodating container, image forming device, image forming method, cured matter, and acrylamide compound RICOH COMPANY, LTD. (JP) 2020-09-22 US disclosed
US-20200038310-A1 COMPOSITION, ARTIFICIAL NAIL COMPOSITION, NAIL DECORATION MATERIAL, ARTIFICIAL NAIL, STORED CONTAINER, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD RICOH COMPANY, LTD. (JP) 2020-02-06 US disclosed
US-20200038309-A1 COMPOSITION, ARTIFICIAL NAIL COMPOSITION, NAIL DECORATION MATERIAL, ARTIFICIAL NAIL, STORED CONTAINER, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD RICOH COMPANY, LTD. (JP) 2020-02-06 US disclosed
EP-3321333-A1 CURABLE COMPOSITION, CURABLE INK, ACCOMMODATING CONTAINER, IMAGE FORMING DEVICE, IMAGE FORMING METHOD, CURED MATTER, AND ACRYLAMIDE COMPOUND Ricoh Company Ltd. (JP) 2018-05-16 EP disclosed
US-20180127607-A1 CURABLE COMPOSITION, CURABLE INK, ACCOMMODATING CONTAINER, IMAGE FORMING DEVICE, IMAGE FORMING METHOD, CURED MATTER, AND ACRYLAMIDE COMPOUND RICOH COMPANY, LTD. (JP) 2018-05-10 US disclosed
US-20180127607-A1 CURABLE COMPOSITION, CURABLE INK, ACCOMMODATING CONTAINER, IMAGE FORMING DEVICE, IMAGE FORMING METHOD, CURED MATTER, AND ACRYLAMIDE COMPOUND RICOH COMPANY, LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10781325-B2 Curable composition, curable ink, accommodating container, image forming device, image forming method, cured matter, and acrylamide compound CRYAA, CDKN1A, ACR ALDH1A1 498/4885ZDHHC20 3181/4885ZDHHC2 3342/4885
US-20180127607-A1 CURABLE COMPOSITION, CURABLE INK, ACCOMMODATING CONTAINER, IMAGE FORMING DEVICE, IMAGE FORMING METHOD, CURED MATTER, AND ACRYLAMIDE COMPOUND CRYAA, CDKN1A, ACR ALDH1A1 498/4885ZDHHC20 3181/4885ZDHHC2 3342/4885
US-20200038309-A1 COMPOSITION, ARTIFICIAL NAIL COMPOSITION, NAIL DECORATION MATERIAL, ARTIFICIAL NAIL, STORED CONTAINER, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD NACA, PIK3C3, DPM1 ALDH1A1 1704/4885ZDHHC20 3546/4885ZDHHC2 3361/4885
US-20200038310-A1 COMPOSITION, ARTIFICIAL NAIL COMPOSITION, NAIL DECORATION MATERIAL, ARTIFICIAL NAIL, STORED CONTAINER, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD NACA, PIK3C3, ACR ALDH1A1 2115/4885ZDHHC20 3530/4885ZDHHC2 3485/4885
US-11529302-B2 Composition, artificial nail composition, nail decoration material, artificial nail, stored container, image forming apparatus, and image forming method NACA, PIK3C3, ACR ALDH1A1 2115/4885ZDHHC20 3530/4885ZDHHC2 3485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.